AI-driven platform for early cancer detection and clinical decision support.
Category: Specialized. Pricing: current comparable pricing is not verified; check the vendor's website. Last modified: 2026-09-11.
C the Signs is an AI-powered clinical decision support system designed to assist healthcare providers in identifying patients at risk for cancer. By leveraging thousands of validated data points, the platform enables clinicians to make informed referral decisions in under 60 seconds. It aims to improve early diagnosis rates and promote equitable health outcomes within primary care settings.
Not editorially tested: One AI Guide has not published a complete hands-on test record for this tool.
Published by LUMIVEX for One AI Guide.
Editorial lead: Said El Moussaoui. Our methodology is published at /how-we-rate.
Official vendor website: see the vendor link below.
No currently verified source links are available for this tool.
These are sourced comparison facts, not hands-on test results. Partial facts need more confirmation; stale facts need a fresh check.
No comparison claims have been checked for this tool.
C the Signs is a specialized tool. AI-driven platform for early cancer detection and clinical decision support.
C the Signs is current comparable pricing is not verified; check the vendor's website. Always check the vendor's site for the latest plans before signing up.
The catalog does not currently record C the Signs as Free or Freemium. That is not proof that no trial or limited offer exists; check the vendor's site for current options.
Common use cases include Early cancer risk assessment, Clinical referral pathway optimization, and Improving health equity in cancer screening.
The One AI Guide catalog currently highlights these strengths: High clinical sensitivity in identifying cancer risk; Reduces time to diagnosis with sub-minute processing; Validated by extensive peer-reviewed clinical research.